Natural killer (NK) cells function in the recognition and destruction of host cells infected with pathogens. Many regulatory mechanisms govern the potent responses of NK cells, both at the cellular and molecular level. Ablation of microRNA (miRNA) processing enzymes demonstrated that miRNAs play critical roles in NK cell differentiation and function; however, the role of individual miRNAs requires further investigation. Using mice containing a targeted deletion of microRNA-155 (miR-155), we observed defects in NK cell maintenance and maturation at steady state, as well as in homeostatic proliferation in lymphopenic mice. In addition, we discovered that miR-155 is up-regulated in activated NK cells during mouse cytomegalovirus (MCMV) infection in response to signals from the proinflammatory cytokines IL-12 and IL-18 and through signal transducer and activator of transcription 4 (STAT4) signaling. Although miR-155 was found to be dispensable for cytotoxicity and cytokine production when triggered through activating receptors, NK cells lacking miR-155 exhibited severely impaired effector and memory cell numbers in both lymphoid and nonlymphoid tissues after MCMV infection. We demonstrate that miR-155 differentially targets Noxa and suppressor of cytokine signaling 1 (SOCS1) in NK cells at distinct stages of homeostasis and activation. NK cells constitutively expressing Noxa and SOCS1 exhibit profound defects in expansion during the response to MCMV infection, suggesting that their regulation by miR-155 promotes antiviral immunity.
Natural killer (NK) cells function in the recognition and destruction of host cells infected with pathogens. Many regulatory mechanisms govern the potent responses of NK cells, both at the cellular and molecular level. Ablation of microRNA (miRNA) processing enzymes demonstrated that miRNAs play critical roles in NK cell differentiation and function; however, the role of individual miRNAs requires further investigation. Using mice containing a targeted deletion of microRNA-155 (miR-155), we observed defects in NK cell maintenance and maturation at steady state, as well as in homeostatic proliferation in lymphopenic mice. In addition, we discovered that miR-155 is up-regulated in activated NK cells during mouse cytomegalovirus (MCMV) infection in response to signals from the proinflammatory cytokines IL-12 and IL-18 and through signal transducer and activator of transcription 4 (STAT4) signaling. Although miR-155 was found to be dispensable for cytotoxicity and cytokine production when triggered through activating receptors, NK cells lacking miR-155 exhibited severely impaired effector and memory cell numbers in both lymphoid and nonlymphoid tissues after MCMV infection. We demonstrate that miR-155 differentially targets Noxa and suppressor of cytokine signaling 1 (SOCS1) in NK cells at distinct stages of homeostasis and activation. NK cells constitutively expressing Noxa and SOCS1 exhibit profound defects in expansion during the response to MCMV infection, suggesting that their regulation by miR-155 promotes antiviral immunity.
T he natural killer (NK) cell response against mouse cytomegalovirus (MCMV) infection has been shown to consist of several distinct phases (1, 2) . Early after viral infection, NK cells respond to type I interferons and proinflammatory cytokines, and produce cytokines and lytic molecules. The subset of NK cells bearing the Ly49H receptor, which recognizes the m157 glycoprotein encoded by MCMV, is able to specifically kill virally infected cells through the secretion of perforin and granzymes (1, 2) . Interestingly, Ly49H
+ NK cells are able to undergo a clonallike proliferation to amass a large number of virus-specific effector NK cells (1, 2) . After contraction of the majority of the effector NK cells, a small pool of long-lived memory NK cells reside in both lymphoid and nonlymphoid organs for months after systemic MCMV infection is resolved (3) . In addition, NK cells undergo homeostatic proliferation in lymphopenic environments and also generate long-lived progeny able to proliferate robustly and mediate effector functions against pathogens (4) . The factors that promote and regulate the distinct stages of both the virusspecific NK cell response and the homeostatic proliferation of NK cells remain to be elucidated.
Recent studies have shown that microRNAs (miRNAs) play an important role in the regulation of NK cell development and function (5) (6) (7) . Conditional gene ablation of the miRNAprocessing enzymes Dicer or Dgcr8, which leads to a global loss of miRNAs, resulted in an impaired survival of maturing NK cells (6, 8) . Furthermore, NK cells lacking miRNAs have been shown to exhibit defects in proliferation and IFN-γ secretion after viral infection (6, 8) . Although individual miRNAs that regulate the development and function of T-cell and B-cell subsets and myeloid lineage cells have been identified (9, 10) , few reports have investigated a similar role for specific miRNAs in NK cell development and effector function. Recently, miR-150 was shown to regulate the development of NK cells by antagonizing the expression of transcription factor c-Myb, as mice with a targeted deletion of miR-150 are impaired in NK cell maturation and function (11) .
The function and several gene targets of the highly conserved miR-155 have been well characterized in multiple immune cell populations (10, 12) . The product of a non-protein-encoding transcript of the Bic gene (13, 14) , miR-155 is abundantly expressed by many cells of the immune system, especially in response to activating stimuli (10, 12) . Several groups have reported an immunodeficiency and widespread immune dysregulation in miR-155-deficient mice (15, 16) . miR-155 has been demonstrated to regulate B-cell responses and the germinal center reaction (16) (17) (18) (19) , helper CD4 + T-cell differentiation and function (15, 16, 20) , generation and homeostasis of regulatory T cells (21) , and maturation and activation of macrophages and dendritic cells (22, 23) . Although miR-155 is expressed in resting NK cells and is further up-regulated on activation, its precise role in NK cell development and function has not been investigated until now. Here we show that miR-155 is critically required for NK cell maturation and maintenance at steady state, as well as for NK cell responses to viral infection in vivo.
Results
Accelerated Maturation of NK Cells from miR-155-Deficient Mice.
miR-155 regulates functions in both innate (macrophages and dendritic cells) and adaptive (B and T cells) immune cells (10, 12, 23) . Because NK cells develop from the same common lymphoid progenitor cell that gives rise to B and T cells, we investigated a role for miR-155 in development. We evaluated NK cell numbers, subsets, phenotype, and function in various tissues of miR-155-deficient and WT mice. The overall number of NK cells in the spleens and livers did not differ significantly between miR-155 −/− and WT mice (Fig. 1A) . Interestingly, the most mature NK cell population, characterized as CD27 lo CD11b hi and expressing Ly49D receptors, Ly49H receptors, or both, was elevated in the miR-155 −/− mice compared with WT mice ( Fig. 1 B and C) . A corresponding decrease in the less-mature NK cell population (CD27 hi CD11b lo or Ly49D − H − ) was evident in spleen and liver, but not in bone marrow, of miR-155 −/− mice ( Fig. 1 B and C) . Thus, miR-155 appears to be less critical for NK cell development in the bone marrow, but has an important role in NK cell maturation and homeostasis in peripheral lymphoid and nonlymphoid tissues.
To investigate the in vivo cytotoxic potential of NK cells in miR-155 −/− and WT mice, both "missing self" B2m −/− and viral m157-expressing (m157Tg) splenocytes were injected along with WT splenocytes as a control. Both groups of mice eliminated the B2m −/− and m157Tg targets equally well (Fig. 1D ), demonstrating that miR-155 −/− NK cells exhibited normal lytic function at steady state. In accordance with these in vivo killing assays, WT and miR-155 −/− NK cells were equally able to kill a variety of NK-sensitive target cells (Fig. S1A ) and produce IFN-γ when triggered through activating receptors or with proinflammatory cytokines (Fig. S1B) . Thus, although homeostatic maturation of NK cells is dependent on miR-155, miR-155 deficiency does not impact cytotoxicity or cytokine secretion by peripheral NK cells. Fig. 2A) . In WT and miR-155 −/− mice given BrdU, miR-155 −/− NK cells exhibited less uptake of BrdU in the spleen, liver, and bone marrow (Fig.  2B) . Taken together, these findings suggest that NK cells lacking miR-155 either are not able to undergo homeostatic proliferation to fill the peripheral NK cell "niche" or are less able to survive in the periphery.
To (Fig. 2C) . The percentage of miR-155 −/− NK cells continued to decline over time, and by day 45 represented less than 15% of the total NK cell population (Fig. 2D) . Although the rate of division during homeostatic proliferation did not differ significantly between the two cell populations (Fig. S2A) , the reduced miR-155 −/− NK cell percentage was observed in multiple tissues (Fig. S2B) . Taken together, these findings suggest that the differences in cell numbers observed on day 7 and beyond reflect a survival defect in miR-155 −/− NK cells during homeostatic proliferation.
Proinflammatory Cytokines Drive High miR-155 Expression in NK Cells.
Because miR-155 is critical for the homeostasis of NK cells, we investigated whether miR-155 also plays a role in the NK cell response against pathogens. We first investigated whether miR-155 is modulated in NK cells during viral infection. During MCMV infection in WT mice, miR-155 expression was rapidly up-regulated in NK cells at day 2 postinfection (PI), with levels returning to baseline by days 4 and 7 PI (Fig. 3A) . To identify the specific signals that drive miR-155 expression, we cultured purified NK cells overnight with various proinflammatory cytokines and measured induction of miR-155 by quantitative RT-PCR (qRT-PCR). A combination of IL-12 and IL-18 resulted in a significant up-regulation of miR-155 in cultured NK cells, whereas individual cytokines alone induced smaller increases in miR-155 levels (Fig. 3B) . Ligation of Ly49H did not result in appreciable miR-155 up-regulation, further suggesting that miR-155 is driven by proinflammatory cytokines produced immediately after infection, and not by activating receptor signaling. We investigated what signaling pathways might mediate the effect of proinflammatory cytokines on miR-155 induction. Because IL-12 signals are known to induce phosphorylation and nuclear translocation of the transcription factor signal transducer and activator of transcription 4 (STAT4), we investigated the presence of consensus STAT4-binding motifs in the promoter of the Bic gene that encodes miR-155, and identified several putative STAT4-binding sites (Fig. 3C) . ChIP of resting versus activated NK cells using an anti-STAT4 antibody followed by qRT-PCR confirmed activation-dependent binding of STAT4 to a site within the conserved noncoding sequence ∼2-kb upstream from the Bic promoter (Fig. 3D ). This finding suggests that STAT4 mediates enhanced expression of miR-155 in activated NK cells. Together, these experiments demonstrate that upregulation of miR-155 in NK cells occurs during viral infection in response to proinflammatory cytokines.
Defective Expansion of miR-155
−/− NK Cells During MCMV Infection.
We investigated whether miR-155 plays a role during the viraldriven proliferation of NK cells. To exclude pleiotropic differences between WT and miR-155 −/− mice, we took advantage of the mixed bone marrow chimeric mice described above and NK cell adoptive transfer systems (3, 4) . We generated chimeric mice with equal numbers of mature WT and miR-155 −/− NK cells by reconstituting irradiated recipients with twice as many bone marrow cells from miR-155 −/− mice as from WT mice (Fig. 4A) . On MCMV infection, we observed a preferential expansion of WT effector Ly49H
+ NK cells at day 7 PI (Fig. 4A) , with an average of 85% WT cells and only 15% miR-155 −/− cells (Fig. 4B) . Thus, miR-155 is absolutely crucial for the productive expansion of effector NK cells in response to MCMV infection.
Early after MCMV infection of the mixed bone marrow chimeras, WT and miR-155
−/− NK cells demonstrated similar activation phenotypes and function, along with comparable up-regulation of activation markers, phosphorylation of STAT proteins, and production of IFN-γ and granzyme B (Fig. S3A) . Consistent with miR-155-mediated effects on expansion at later time points in the NK cell response against MCMV infection, phenotypic differences were observed between WT and miR-155 −/− NK cells at day 7 PI. A higher percentage of WT NK cells expressed killer cell lectin-like receptor subfamily G member 1 (KLRG1) and were CD27 lo CD11b hi (Fig. S3B) , demonstrating an enhanced activation state that presumably correlates with the increased expansion; interestingly, cytotoxicity was comparable in the WT and miR-155 −/− NK cells. These findings indicate that miR-155 exerts specific influences over only certain NK cell effector mechanisms and not others during viral infection.
We also evaluated NK cells that had already undergone homeostatic proliferation for their ability to undergo antigen-driven expansion in response to MCMV infection. At 50 d after the initial transfer of WT or miR-155
−/− mice, with the ratio of WT:miR-155 −/− Ly49H + NK cells at ∼2:1 (Fig. S4A) , the mice were challenged with MCMV infection. Strikingly, the ratio of WT:miR-155 −/− Ly49H + NK cells grew to nearly 10:1 (Fig. S4B) . To determine whether the number of miR-155 −/− Ly49H + NK cells was also diminished in lymphoid and nonlymphoid organs, we killed the mice at day 10 PI and found a ratio of WT:miR-155 −/− Ly49H + NK cells of 30:1 in the spleen and 20:1 in the liver at this later time point (Fig. 4C) . In both spleen and liver, the defective miR-155 −/− Ly49H + NK cell response was characterized by reduced down-regulation of CD62L and up-regulation of KLRG1, in addition to a decrease in mature or activated CD27 lo CD11b hi NK cells compared with the less-mature CD27
hi CD11b lo NK cell population (Fig. S4C) . The pronounced phenotype observed in the adoptive transfer compared with the mixed chimera setting may be explained in part by the greater fold expansion of Ly49H + NK cells during viral infection after adoptive transfer of NK cells.
Generation of NK Cell Memory Depends on miR-155. Because recent studies in both mice and humans have suggested that the lifespan of previously activated NK cells is on the order of months and years rather than days and weeks (1), we investigated whether miR-155 influences the longevity of "memory" NK cells after MCMV infection. Equal numbers of purified WT or miR-155
Ly49H
+ NK cells were adoptively transferred into Ly49H-deficient mice, and percentages of Ly49H + NK cells in each group were determined at various time points after MCMV infection. WT Ly49H + NK cells proliferated robustly in the Ly49H-deficient hosts, in contrast to the miR-155 −/− Ly49H + NK cells (Fig. 5A ). After the contraction of effector NK cells, larger numbers of long-lived memory NK cells were found within the WT group compared with the miR-155 −/− group (Fig. 5A ). The ratio of WT:miR-155 −/− cells increased incrementally from day 7 PI (5:1) to day 14 PI (7:1) and finally to day 45 PI (13:1) (Fig. 5B) , suggesting that miR-155 limits the contraction of effector NK cells during the memory maintenance phase.
Interestingly, although the overall numbers of Ly49H + NK cells begin to favor the WT over miR-155 −/− NK cells as early as day 4 PI, little difference in proliferation, as measured by dilution of carboxyfluorescein succinimidyl ester (CFSE), was observed between the two groups at day 4 or day 5 PI (Fig. 5C) We investigated the genes that miR-155 may be targeting during NK cell homeostasis and activation, which might contribute to the expansion and survival defects observed in miR-155 −/− NK cells after viral infection. We considered miR-155-binding sites that were identified through Argonaute cross-linking immunoprecipitation with high-throughput sequencing (CLIP-seq) (24) . CLIP-seq identified two miR-155-binding sites in the 3′ UTR of the Noxa transcript (Fig. 6A) , one of which was highly conserved across species (Fig. 6B) . A previous report suggested that Noxa, a proapoptotic Bcl-2 homology domain (BH3)-only protein, is an important regulator of survival in NK cells (25) . The CLIP-seq results also support miR-155 targeting of previously defined sites in suppressor of cytokine signaling 1(SOCS1), an important regulator of T-cell homeostasis (21) .
To confirm direct regulation of Noxa and SOCS1 by miR-155, we generated luciferase reporter constructs containing the 3′ UTR of Noxa or of SOCS1 and cotransfected each of these with constructs expressing miR-155 or a control miRNA, miR-146a. Cotransfection of the Noxa 3′ UTR with miR-155 resulted in significant repression of reporter activity (Fig. 6C) . The SOCS1 3′ UTR was similarly repressed by miR-155, although to a lesser degree (Fig. 6C) .
To determine whether miR-155 targets Noxa and SOCS1 in resting or activated NK cells, we sorted WT and miR-155
+ NK cells from WT:miR-155 −/− chimeric mice at day 0, 2, 4, and 7 after MCMV infection and determined transcript levels of Noxa and Socs1 by qRT-PCR. Compared with WT NK cells, miR-155 −/− NK cells expressed higher levels of Noxa mRNA at day 0 PI (uninfected mice) and Socs1 mRNA at day 7 PI (Fig. 6D) .
To examine whether the elevated levels of Noxa or SOCS1 detected in miR-155 −/− NK cells could be responsible for the expansion phenotype exhibited by these cells, we generated retrogenic mice in which Noxa or SOCS1 (or a control GFP vector) were constitutively expressed in half of the hematopoietic compartment (Fig. 6E) . After MCMV infection, the NK cell response of the "Noxa Tg" or "SOCS1 Tg" populations was compared with that of the control retrogenic WT (GFP only) population. We observed that both Noxa-and SOCS1-expressing NK cells did not proliferate comparably to the control WT NK cells after MCMV infection, with WT NK cells expanding >10-fold and >6-fold more, respectively (Fig. 6F) . Surprisingly, the known miR-155 target, Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP-1), was not elevated in miR-155 −/− NK cells during infection (Fig. S5A) , and overexpression experiments with SHIP-1 demonstrated no differences in NK cell responses (Fig. S5B) . Together, these studies suggest that miR-155-mediated regulation of Noxa and SOCS1 can promote a robust NK cell response against MCMV infections.
Discussion
The activation and regulation of potent NK cell responses is known to occur at the cellular and molecular levels, and to include both cell-extrinsic and -intrinsic signals. Cross-talk between NK cells and other cells of the immune system via proinflammatory cytokines and surface receptors acts to drive NK cell activation as well as inhibition (26) . For example, cytokines such as IL-12, IL-18, and type I IFNs, produced by cells such as dendritic cells, initiate NK cell responses against pathogens (1). At the same time, potent NK cells must be restrained after pathogen clearance to limit "collateral damage" to healthy tissues; regulatory cytokines, such as IL-10 and TGF-β, have recently been suggested to constrain NK cell activity (27, 28) . NK cells also express both activating and inhibitory receptors, which when ligated dictate the magnitude and duration of the effector response (26) . NK cell responses may be further regulated by changes in gene expression. The role of miRNAs in regulating the transcriptome of many immune cell populations has been described (12, 29) . Studies in which global miRNA ablation was achieved through the deletion of genes encoding miRNAprocessing enzymes Dicer and Dgcr8 in mice have demonstrated severe defects in NK cell development and function (6, 8) . In the present study, we present evidence indicating that a specific miRNA, miR-155, is critical for regulating the in vivo maturation, homeostasis, and antiviral response of NK cells. Deletion of miR-155 resulted in enhanced maturation of NK cells, along with a reduction in immature NK cell populations that are less differentiated but have greater proliferative potential. An increase in the number of terminally differentiated resting NK cells in miR-155-deficient populations may explain why these cells cannot compete with WT NK cells in homeostatic and lymphopenic environments. Given that the proapoptotic molecule Noxa has been implicated as an antagonist of myeloid cell leukemia sequence 1 (Mcl-1), a critical factor in IL-15-mediated survival of NK cells (25) , and that we have validated Noxa as a functionally important target of miR-155, a mechanism might exist in which developing and resting NK cells require low levels of miR-155 to suppress Noxa levels for enhanced NK cell survival and homeostasis (Fig. S6A) . Consistent with this hypothesis, a recent study suggested that miR-155 protects macrophages from apoptosis through its regulation of multiple proapoptotic genes, including Noxa (30) . Although Noxa mRNA levels did not differ greatly in WT and miR-155 −/− NK cells after viral infection, miR-155-mediated suppression of Noxa, in addition to numerous other gene targets, may still be a contributing factor to the preferential expansion and memory maintenance of WT compared with miR-155 −/− or Noxa-expressing NK cells observed after MCMV infection.
During MCMV infection, miR-155 was absolutely required for a robust NK cell response. A recent study in regulatory T cells demonstrated that miR-155 targets SOCS1, resulting in loss of protein, but not of SOCS1 mRNA expression (21) . In contrast, activated NK cells lacking miR-155 had elevated levels of SOCS1 transcripts compared with WT NK cells after viral infection (Fig. S6B ). Given that SOCS1 is known to suppress various STATs downstream of proinflammatory cytokine signaling (31), along with our recent demonstration that IL-12 and STAT4 signaling are required for the generation of robust effector and memory cell numbers (32), we hypothesized that miR-155-mediated SOCS1 repression might allow for enhanced NK cell proliferation. In support of our hypothesis, both miR-155-deficient NK cells and NK cells with constitutive SOCS1 expression failed to proliferate substantially after MCMV infection (Fig.  S6B) . Perhaps regulation of this potent suppressor of STAT signals by miRNAs has evolved to confer extensive proliferative and survival advantages during cellular responses against pathogens.
Previous studies have identified SHIP-1 as an important target of miR-155 in human NK cells, as well as in macrophages and B cells (33) (34) (35) (36) . However, we found no differences in SHIP-1 transcript in WT and miR-155 −/− NK cells, or any defects in development or MCMV-induced expansion in NK cells from mixed bone marrow chimeric mice in which SHIP-1 was constitutively expressed by retroviral transduction. Whether regulation of SHIP-1 by miR-155 is a cell type-or species-specific phenomenon that does not occur in mouse NK cells, or whether regulation occurs but is nevertheless dispensable for mouse NK cell function, is unknown. With respect to the latter, we have previously shown that both resting and activated mouse NK cells harbor very high levels of SHIP-1 (37, 38) , such that targeting by miR-155 may have an inconsequential effect on the overall abundance of SHIP-1. Whether the plethora of SHIP-1 mRNA acts as a "sink" for miR-155 in NK cells (39) and reduces the availability of miR-155 for other mRNA targets remains to be investigated. Although additional targets of miR-155 regulate NK cell development, homeostasis, and response against pathogens remain to be identified, the present study suggests that miR-155 is able to influence the NK cell response in a multifaceted manner, targeting distinct cell-intrinsic pathways of effector cell function, cell cycle, and survival.
Materials and Methods
Mice, Adoptive Transfer, Chimeras, and Viral Infection. Detailed descriptions of the WT and KO strains of mice used in this study are provided in SI Materials and Methods. Adoptive transfer experiments were performed and mixed bone marrow chimeric mice were generated as described previously (3). Mice overexpressing Noxa, SOCS1, and SHIP-1 were generated as described previously (40) ; details are provided in SI Materials and Methods. Mice were infected by i.p. injection of Smith strain MCMV (10 4 pfu).
NK Cell Stimulation and Quantitative RT-PCR. Total RNA (including miRNA) was extracted from NK cells stimulated with antibodies or cytokines, or sorted from naïve and infected mice. Amounts of miR-155, Noxa, SOCS1, and controls were measured by qRT-PCR. Detailed descriptions of protocols and primers are provided in SI Materials and Methods.
ChIP, Argonaute CLIP-seq, and Luciferase Reporter Assays. ChIP was performed on NK cells activated with recombinant mouse IL-12 (20 ng/mL) and IL-18 (10 ng/ mL) using an anti-STAT4 Ab or control IgG, and relative amounts of target DNA were determined by qRT-PCR. Argonaute CLIP-seq was performed on WT and miR-155-deficient T cells (24) . Luciferase reporter assays were performed by transfection with expression vectors containing miR-155 (or control miRNA), along with vectors containing the 3′ UTR of target genes. Detailed descriptions of protocols, plasmids, and primers are provided in SI Materials and Methods.
